Adicet Bio

Adicet Bio

Adicet Bio is a biotechnology company creating immune cell therapies for treating cancer and other diseases.

Adicet Bio is a biotechnology company creating immune cell therapies for treating cancer and other diseases that is headquartered in Menlo park, California and was founded in 2014 by Aya Jakobovitis.

Funding

Venture

On August 26, 2015 Adicet Bio completed a venture capital round raising $14.6 million in funding from undisclosed investors.

Series A

On January 27, 2016 Adicet Bio completed their series A funding round with $51 million in funding from OrbiMed (lead investor), Pontifax, and Novartis Venture Fund.

Acquisitions

Applied Immune Technologies

On January 27, 2016 Adicet Bio acquired the Israeli immunotherapy company Applied Immune Technologies.

Timeline

January 27, 2016

Series A funding round

On January 27, 2016 Adicet Bio completed their series A funding round with $51 million in funding from OrbiMed (lead investor), Pontifax, and Novartis Venture Fund.

August 26, 2015

Venture funding round

On August 26, 2015 Adicet Bio completed a venture capital round raising $14.6 million in funding from undisclosed investors.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Adicet Bio funding round, October 2019
80,000,000
October 2019
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.